Polaryx Therapeutics PLYX
NASDAQ PLYX
$2.08 +0.06 (+2.97%)
At close: Oct 2, 2026 · 4:00 PM EDT

Polaryx Therapeutics (PLYX) Selling, General & Administrative (2025 - 2026)

Updated

Polaryx Therapeutics' Selling, General & Administrative was $661,000 in Q2 2026, up 62.0% from $408,000 a year earlier but down 48.3% from the prior quarter.

Analysis

Polaryx Therapeutics (PLYX) Selling, General & Administrative (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Polaryx Therapeutics' Selling, General & Administrative was $2.68 million through Jun 30, 2026; for FY2025, it was $1.56 million, up 0.9% from FY2024.

  • In earlier years, Selling, General & Administrative was $1.54 million in FY2024.
  • Quarterly Selling, General & Administrative has moved between $336,000 (Q1 2025) and $1.28 million (Q1 2026) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Polaryx Therapeutics 103.68 Mn 79.29 Mn - 661,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 661,000.00
Mar 31, 2026 1.28 Mn
Jun 30, 2025 408,000.00
Mar 31, 2025 336,000.00
API Access

Polaryx Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=PLYX&period=max&api_key=YOUR_API_KEY